BAY79-4620

· Bayer

Drug timelines are a Plus or Pro feature.

2 regulatory and trial events tracked for BAY79-4620, covering 2014-10-01 to 2015-01-21. Get the full timeline:

Most recent: Clinical Trial Update: To Determine Maximum Tolerated Dose of BAY79-4620 in Patients With Advanced Solid Tumors [Phase 1]